CATALYST BIOSCIENCES INC (CBIO)       0.295  -0.01 (-2.99%)

0.295  -0.01 (-2.99%)

US14888D2080 - Common Stock - After market: 0.3 +0.01 (+1.69%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.16 -0.10 -0.06-56.86% Q2 2022 -0.18 -0.25 0.0727.97% Q1 2022 -0.46 -0.45 -0.01-1.73% Q4 2021 -0.64 -0.60 -0.04-6.80% Q3 2021 -0.80 -0.67 -0.13-18.84% Q2 2021 -0.64 -0.71 0.079.72% Q1 2021 -0.79 -0.59 -0.20-34.11% Q4 2020 -0.86 -0.88 0.022.24%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 0.92 -2.87 131.99%Q4 2022 -0.13 -0.64 79.28%FY 2023 -0.37 0.92 -140.00%Q1 2023 -0.10 -0.46 77.83%Q2 2023 -0.09 -0.18 49.00%Q3 2023 -0.09 -0.16 42.63%Q4 2023 -0.08 -0.13 38.46%FY 2024 -0.30 -0.37 19.44%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 % Q2 2022 % Q1 2022 794K 794K∞% Q4 2021 2.44M 170.003K 2.27M1,335.27% Q3 2021 2.299M 688.5K 1.611M233.91% Q2 2021 1.132M 339.997K 792.003K232.94% Q1 2021 1.47M 816K 654K80.15% Q4 2020 2.03M 51K 1.979M3,880.39%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 809.88K 7.338M -88.96%Q4 2022 2.44M -100.00%FY 2023 809.88K -100.00%Q1 2023 794K -100.00%Q2 2023 %Q3 2023 %Q4 2023 %FY 2024 %FY 2025 %FY 2026 %FY 2027 %FY 2028 %FY 2029 %FY 2030 %